Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 131
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
A Practitioner Statement on the Responsible Development of Ibogaine in the United States – Open Letter
Dr. Michael Alpert and Peter Alberding – ALS, Existential Distress, and Ketamine Therapy
Pα+ Psychedelic Bulletin #223: Ibogaine Advocates Court Trump, via Rogan; Compass Launches Provider Training Grants; Therapeutic Alliance Debate Reignites
Psychedelic Funding Update: Q1 2026
Inclius Alvarious’s Place Within Indigenous Society
Psychedelic Bulletin #129: New Year, New Psychedelic Bills; WHO Dubs 5-MeO-DMT...
Algernon Pharmaceuticals Appoints Dr. Peter Dicpinigaitis to Chronic Cough Advisory Board
Psychedelics Weekly – Prince Harry and Psychedelics, Proposed Legalization, and The...
Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation
atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from...
atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from...
atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from...
Bright Minds Biosciences Announces Resignation of Board Member
Jaguar Health and Filament Health, with Funding from One Small Planet,...
Psychedelic Research Bulletin: December 2022
Load more